SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
25
NOTIFICATION
OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission
File Number 1-13602
The
Female Health Company –
NYSE Amex
LLC
(Exact
name of Issuer as specified in its charter, and name of Exchange where security
is listed and/or registered):
515
North State Street,
Suite 2225, Chicago, Illinois
60654
(Address,
including zip code, and telephone number, including area code, of Issuer's
principal executive offices):
|
(Description
of class of securities):
|
Common
Stock, $0.01 par value
|
Please
place an X in the box to designate the rule provisions relied upon to strike
the
class of securities from listing and registration:
[ ] 17
CFR 240.12d2-2(a)(1)
[ ] 17
CFR 240.12d2-2(a)(2)
[ ] 17
CFR 240.12d2-2(a)(3)
[ ] 17
CFR 240.12d2-2(a)(4)
[ ]
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules
to
strike the class of securities from listing and/or withdraw registration on
the
Exchange.
[X]
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of
the
Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary
withdrawal of the class of securities from listing and registration on the
Exchange.
Pursuant
to the requirements of the Securities Exchange Act of 1934, The Female Health
Company certifies that it has reasonable grounds to believe that it meets all
of
the requirements for filing the Form 25 and has caused this notification to
be
signed on its behalf of the undersigned duly authorized person.
|
June 8,
2009
|
By
/s/
Donna
Felch
Name:
Donna Felch
Title:
Vice President and
Chief
Financial Officer
|